New immune therapy aims to keep aggressive leukemia at bay
NCT ID NCT04229979
Summary
This study is for adults with acute myeloid leukemia (AML) who have achieved a second remission after their cancer returned. It compares a new immunotherapy called Galinpepimut-S (GPS) against the doctor's choice of standard available treatments. The main goal is to see if GPS helps people live longer by keeping the leukemia from coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
All India Institute of Medical Sciences
New Delhi, 110029, India
-
Augusta University
Augusta, Georgia, 30912, United States
-
Baylor Scott and White Research Institute
Dallas, Texas, 75246, United States
-
Bon Secours St. Francis Cancer Center
Greenville, South Carolina, 29607, United States
-
C.H. Regional Reina Sofia
Córdoba, 14004, Spain
-
CHU Amiens-Picardie - Hopital Sud
Amiens, 80000, France
-
CHU Angers
Angers, 49000, France
-
CHU de Caen
Caen, 14000, France
-
CHU de Grenoble
Grenoble, 38043, France
-
CHU de Poitiers
Poitiers, 86000, France
-
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69310, France
-
Changhua Christian Hospital
Chang-hua, 50006, Taiwan
-
Clinica Universidad Navarra
Pamplona, 31008, Spain
-
Clinical Centre of Vojvodina
Novi Sad, 402007, Serbia
-
Colorado Blood Cancer Institute - SCRI - PPDS
Denver, Colorado, 80218, United States
-
Complejo Asistencial Universitario de Salamanca
Salamanca, 37007, Spain
-
Fortis Hospital
Ludhiāna, 141015, India
-
General Hospital of Athens "Evaggelismos"
Athens, 10676, Greece
-
General Hospital of Athens "G. Gennimatas"
Athens, 11527, Greece
-
General Hospital of Athens "Laiko"
Athens, 11526, Greece
-
General Hospital of Athens "Ηippokration"
Athens, 11527, Greece
-
General Hospital of Thessaloniki "G. Papanikolaou"
Chortiatis, 57010, Greece
-
Hospital General Universitario Gregorio Marañon
Madrid, 28007, Spain
-
Hospital Universitari i Politecnic La Fe de Valencia
Valencia, 46026, Spain
-
Hospital Universitario Central de Asturias
Oviedo, 33011, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario Virgen del Rocio
Seville, 41013, Spain
-
Hospital de San Pedro de Alcantara
Cáceres, 10003, Spain
-
Hôpital Saint Antoine
Paris, 75571, France
-
Hôtel Dieu - Nantes
Nantes, 44000, France
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Instytut Hematologii i Transfuzjologii
Warsaw, 02-776, Poland
-
Kaohsiung Medical University Hospital
Kaohsiung City, 807, Taiwan
-
Klinikum Chemnitz gGmbH
Chemnitz, 09116, Germany
-
Malabar Cancer Centre
Kannur, Kerala, 670103, India
-
Mayo Clinic Jacksonville Florida
Jacksonville, Florida, 32224, United States
-
National Cheng Kung University Hospital
Tainan, 704, Taiwan
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
New York Medical College
Valhalla, New York, 10532, United States
-
Northwell Health Cancer Institute
Lake Success, New York, 11042, United States
-
O'Neal Comprehensive Cancer Center
Birmingham, Alabama, 35205, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Petz Aladár Egyetemi Oktató Kórház
Győr, 9028, Hungary
-
Pécsi Tudományegyetem
Pécs, 7624, Hungary
-
Rush University Cancer Center
Chicago, Illinois, 60612, United States
-
SP ZOZ Szpital Uniwersytecki w Krakowie
Słomniki, 32-090, Poland
-
Semmelweis Egyetem
Budapest, 1088, Hungary
-
State Cancer Institute, Indira Gandhi Institute of Medical Sciences
Patna, 800014, India
-
Swedish Cancer Institute
Seattle, Washington, 98109, United States
-
Swietokrzyskie Centrum Onkologii
Kielce, 25-734, Poland
-
Szpital Uniwersytecki Nr 2 im. Dr Jana Biziela w Bydgoszczy
Bydgoszcz, 85-168, Poland
-
Szpital Wojewodzki w Opolu
Opole, 45-372, Poland
-
Szpitale Pomorskie Sp. z o.o.
Gdynia, 81-519, Poland
-
Taichung Veterans General Hospital
Taichung, 40705, Taiwan
-
The Oncology Institute of Hope and Innovation
Whittier, California, 90603, United States
-
Tulane Cancer Center - Liberty
New Orleans, Louisiana, 70112, United States
-
UCLA Medical Hematology and Oncology
Los Angeles, California, 90095, United States
-
Universitatsklinikum Leipzig
Leipzig, 04103, Germany
-
University Clinical Center of Serbia
Belgrade, 11000, Serbia
-
University General Hospital "Attikon"
Chaïdári, 12462, Greece
-
University General Hospital of Alexandroupoli
Alexandroupoli, 68100, Greece
-
University General Hospital of Ioannina
Ioannina, 45500, Greece
-
University General Hospital of Patras
Rio, 26504, Greece
-
University General Hospital of Thessaloniki "Ahepa"
Thessaloniki, 54636, Greece
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
University of Texas - MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Universitätsklinik Rostock
Rostock, 18057, Germany
-
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu
Wroclaw, 50-367, Poland
-
Uniwersyteckie Centrum Kliniczne Klinika Hematologii i Transplantologii
Gdansk, 80-952, Poland
-
Virginia Cancer Specialists
Gainesville, Virginia, 20155, United States
-
Wojewodzki Szpital Specjalistyczny w Legnicy
Legnica, 59-220, Poland
-
Yashoda Hospital
Hyderabad, 500084, India
-
Zaklad Opieki Zdrowotnej MSW z Warminsko-Mazurskim Centrum Onkologii
Olsztyn, 10-228, Poland
Conditions
Explore the condition pages connected to this study.